3Pienta KJ, Partin AW, Coffey DS. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res, 1989, 49: 2525-2532.
4Wang ZH, Yu D, Li HK, et al. Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment.Anticaneer Res, 2001, 21:493-498.
5Yu D, Wang ZH, Cheng SB, et al. The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells.Anticancer Res, 2001, 21:2553-2559.
6Andre C, Guillemin MC, Zhu J, et al. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp Cell Res, 1996, 229:253-260.
7Fey EG, Penman S. Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci USA ,1988, 85:121-125.
8Shen ZY, Shen J, Cai W J, et al. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int J Mol Med, 2000, 5:155-158.
9Jiang XH, Wong BC, Yuen ST, et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p.53 and activation of caspase-3. Int J Cancer, 2001, 91:173-179.
10Murgo AJ. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the national cancer institute cooperative research and development studies. Oncologist, 2001,6 Suppl 2: 22-28.
